De-Iron

De-Iron: A phase 2 study of the efficacy and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent Myelodysplastic Syndromes

Change of Staff

If there is a change of staff working on the trial please print off and complete the relevant registration form below. Please also ensure that the Signature and Delegation Log is updated. 

Trial Documents

Links to the current protocol, Patient Information Sheet, Informed Consent Form are provided below. If there has been a recent amendment to the trial please ensure you have R&D approval before using these documents.

Other documents (e.g. Amendments, Case Report Form, Serious Adverse Event Form, Guidelines, GP Letter, Release of Medical Information Form etc) can be found by clicking on the other menu items below. If you cannot find what you are looking for please contact the De-Iron Trial Office.

Version Control Lists

The version numbers and dates of all documents used for the trial are captured on a Version Control List. Links to the Version Control Lists used in this trial are below in reverse date order.

Current

Previous versions

 

Amendments

Below is a link to a document which lists all of the substantial protocol amendments which have been made for this trial. The folders below contain the relevant amended documentation and approval letters. Please ensure that you have R&D approval (if applicable) before using the latest versions of these documents.


Guidelines

Other Trial Documents

Publications

To date there are no publications for this trial.

News and Events

Most recent

Archive

Contact Details

Chief Investigator

Dr Dominic Culligan, Consultant Haematologist

NHS Grampian, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, AB25 2ZN

Tel: +44 (0)122 455 3394

Email: De-Iron@trials.bham.ac.uk  

 

De-Iron Trial Office
Trial Coordinator:  Yolande Jefferson                                             
Trial Management Team Leader:  Shamyla Siddique
Trial Statistician:  Aimee Houlton

Cancer Research UK Clinical Trials Unit (CRCTU)
Department of Cancer and Genomic Sciences
University of Birmingham
Edgbaston
Birmingham
B15 2TT

Enquiries
Telephone: +44 (0)121 415 9179
Fax:             +44 (0)121 414 6061
Email:         De-Iron@trials.bham.ac.uk

 

Serious Adverse Event Reporting
Fax: +44 (0)121 414 6061           or  +44 (0)121 414 3700

Sponsor

The trial is sponsored by the University of Birmingham.

The trial is being conducted under the auspices of the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham according to their local procedures.